The relationship between gene polymorphism and the sensitivity of radio therapy for the patients with esophageal squamous cell carcinoma
作者:陈森明1,罗招云2,陈楚芝2,章耀鸿1
单位:1.汕头大学附属潮州市人民医院
肿瘤科,广东 潮州 521000;2.南方医科大学附属潮州市中心医院
中心实验室,广东 潮州 521000
Authors: Chen
Senming1,Luo Zhaoyun2,Chen
Chuzhi2,Zhang Yaohong1
Unit: 1. Department of Oncology,
Chaozhou People's Hospital, Chaozhou 521000, Guangdong,China;2.Medical Laboratory Center, Chaozhou
Central Hospital Affiliated to Southern Medical University, Chaozhou, 521000,
Guangdong, China
摘要:
目的 了解食管鳞癌患者的X射线交错互补修复基因1 (X-ray repair cross
complementing group1,XRCC1)的4个单核苷酸多态性(single nucleotide polymorphisms,SNP)位点的分布情况及其与放疗敏感性的关系。方法
提取175例食管鳞癌患者外周血DNA,通过特异性引物PCR扩增XR CC1的4个SNP所在基因片段,测序及BLAST多态性分析,并与放疗结果相结合,分析SNP与放疗疗效的相关性。结果
175例食管鳞癌患者中有112例能成功扩增并测序XR CC1中4个SNP位点。112例患者全组放疗近期有效率为84.8%,其中,4个SNP位点均未变异的基因型组有效率为74.3%,有1个以上SNP变异的基因型组有效率为89.6%(X2=4.389,P=0.036);单独第4个SNP位点(G28152 A,Arg399Gln)变异的基因型组和所有含第4个SNP位点变异组有效率分别为91.2%和91.5%,与未变异的基因型组比较差异有统计学意义(X2=4.014,P=0.045和X2=4.451,P=0.035)。结论XRCC1中SNP变异基因型组与食管鳞癌患者放疗敏感性相关。其中,第4个SNP位点变异的基因型可能是放疗敏感的预测指标。
关键词:食管鳞癌;X射线修复交叉互补基因;单核苷酸多态性;放射治疗;放射敏感性
Abstract:
Objective To detect four single nucleotide
polymorphisms (SNP) of X-ray repair cross complementing group1 (XRCC1) in the
patients with esophageal squamous cell cancer (ESCC), and learn the
distribution of genotypes of four SNPs among the patients with ESCC. To study
the relationship between four SNPs of XRCC1 and the sensitivity of radio
therapy for the patients with ESCC for clinical history diagnosis. Method The
DNA was extracted the whole blood from 175 cases ESCC patients. The complete
XRCC1 gene sequence was amplified with three pairs of primers, and then
sequenced in Invitrogen Biotechnology Co.Ltd. The BLAST 2.0 software online
were used to analyze and identify mismatches. To analysis the relationship
between four SNPs of XRCC1 and the effectiveness of radio sensitivity by
connecting the result of radio therapy. Results 112 complete XRCC1 genes
were successfully amplified and sequenced in 175 cases of in the patients with
ESCC. The response rate of radiotherapy is 84.8% among 112 cases. The
distribution of genotypes of the SNPs among the radiosensitive and
radio-resistant in the sensitivity of radio therapy for the patients with ESCC,
genotype frequency with and without variation of the four SNPs in XRCC1 genes
was statistic different (X2=4.389, P=0.036). Among the different genotype
group, only group with mutation of G28152A has statistic different sensitivity
to the radiotherapy for ESCC, compared with group with no mutations of the four
SNP in XRCC1 gene (X2=4.014, P=0.045),and all of the groups containing the
fourth mutatio of G28152A has statistic different sensitivity to compared with
group with no mutations of the four SNP in XRCC1 gene(X2=4.451, P=0.035).
Conclusion The polymorphism of four SNPs of XRCC1 are associated with the
sensitivity of radio therapy for the patients with ESCC. The fourth SNP is the
gene type of sensitivity of radio therapy and predictive ability
Key Words: Esophageal
squamous cell carcinoma;X-ray repair cross complementing group1;Single nucleotide polymorphisms;Radio
therapy;Radiosensitivity
关注我们